TAM
FPRX

Trillium Asset Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Trillium Asset Management’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-79,670
Closed -$1.26M – 247
2018
Q2 		$1.26M Buy
79,670
+448
+0.6% +$7.82K 0.07% 175
2018
Q1 		$1.36M Buy
79,222
+20,220
+34% +$394K 0.08% 169
2017
Q4 		$1.29M Sell
59,002
-5,894
-9% -$190K 0.07% 170
2017
Q3 		$2.65M Sell
64,896
-399
-0.6% -$12.5K 0.15% 138
2017
Q2 		$1.97M Buy
65,295
+955
+1% +$29.8K 0.12% 147
2017
Q1 		$2.33M Sell
64,340
-275
-0.4% -$12.1K 0.15% 141
2016
Q4 		$3.24M Buy
64,615
+751
+1% +$39.5K 0.21% 124
2016
Q3 		$3.35M Buy
63,864
+1,419
+2% +$67.8K 0.22% 124
2016
Q2 		$2.58M Buy
+62,445
New +$2.72M 0.17% 141

Other funds holding FPRX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return